Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-08-02 | 2020-02-27 | 17964 |
| LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
| LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
| LOSARTAN | 25MG | TABLET | Resolved | 2018-11-21 | 2019-07-26 | 67318 |
| LOSARTAN | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67324 |
| LOSARTAN | 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-26 | 67327 |
| LOSARTAN | 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82935 |
| LOSARTAN | 50MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82938 |
| LOSARTAN | 25MG | TABLET | Resolved | 2019-07-25 | 2021-05-06 | 89940 |
| LOSARTAN | 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145528 |
| LOSARTAN | 25MG | TABLET | Resolved | 2021-09-13 | 2024-12-03 | 145531 |
| LOSARTAN | 50MG | TABLET | Resolved | 2021-09-13 | 2024-09-17 | 145534 |
| LOSARTAN | 100MG | TABLET | Resolved | 2021-09-20 | 2024-09-17 | 145888 |
| LOSARTAN | 100MG | TABLET | Resolved | 2025-04-01 | 2025-05-16 | 253781 |
| LOSARTAN | 100MG | TABLET | Resolved | 2025-09-03 | 2025-10-09 | 266462 |
| LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67312 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67315 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67321 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82941 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145537 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |